A Therapeutic Strategy for Rett Syndrome and Autism Spectrum Disorders
Invention type: Technology
/
Case number: #12720WPJ
The invention relates to methods for treatment of Rett Syndrome and other disorders of synaptic function and maturation using IGF1, (1-3)IGF-1, (1-3)IGF-1 analog(s) and/or related therapeutic molecules.
Researchers
Daniela Tropea
/
Emanuela Giacometti
/
Rudolf Jaenisch
/
Mriganka Sur
/
Nathan Wilson
Departments: Picower Institute for Learning & Memory, Department of Biology, Department of Brain and Cognitive Sciences
Technology Areas: Therapeutics: Small Molecules
Impact Areas: Healthy Living
-
treatment of rett syndrome and other disorders
United States of America | Granted | 7,994,127 -
treatment of rett syndrome and other disorders
Japan | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.